SMS Pharmaceuticals Reports Strong Financial Growth and Improved Profitability Metrics in March 2025 Results

May 30 2025 08:50 PM IST
share
Share Via
SMS Pharmaceuticals has announced its financial results for the quarter ending March 2025, highlighting significant growth in key metrics. The company achieved its highest operating profit to interest ratio in five quarters, with net sales increasing to Rs 248.20 crore and profit after tax reaching Rs 20.32 crore.
SMS Pharmaceuticals has reported its financial results for the quarter ending March 2025, showcasing notable developments in various key metrics. The company's score has seen an adjustment in evaluation, moving to 14 from 11 over the past three months, reflecting a shift in assessment.

The financial data reveals that SMS Pharmaceuticals achieved its highest operating profit to interest ratio in the last five quarters, recorded at 8.05 times, indicating an enhanced capacity to manage interest obligations. Additionally, net sales reached Rs 248.20 crore, marking a significant growth of 27.2% compared to the average net sales of the previous four quarters, which stood at Rs 195.09 crore.

The operating profit (PBDIT) also reached a peak of Rs 40.81 crore, while profit before tax (PBT) was reported at Rs 27.10 crore, reflecting a growth of 37.0% over the previous four-quarter average. Furthermore, profit after tax (PAT) hit Rs 20.32 crore, growing by 23.0% compared to the average PAT of the last four quarters. Earnings per share (EPS) reached Rs 2.29, indicating an increase in profitability for shareholders.

For more insights, Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
SMS Pharmaceuticals Hits New 52-Week High at Rs.335.25
Nov 27 2025 09:53 AM IST
share
Share Via
SMS Pharmaceuticals Hits New 52-Week High at Rs.335.25
Nov 27 2025 09:53 AM IST
share
Share Via
Is SMS Pharma. overvalued or undervalued?
Nov 27 2025 08:25 AM IST
share
Share Via
Why is SMS Pharma. falling/rising?
Nov 27 2025 12:26 AM IST
share
Share Via